A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
Active, not recruiting · NCT05972473 · Registry updated 2025-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2025-03-13 | NCT05972473 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai General Hospital | Shanghai | China | 59 |